Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

Hao Xie, Alex Adjei

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)S41-S43
JournalTranslational Lung Cancer Research
Volume6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Non-Small Cell Lung Carcinoma
avelumab

ASJC Scopus subject areas

  • Oncology

Cite this

Avelumab : Another active immune checkpoint inhibitor in nonsmall cell lung cancer. / Xie, Hao; Adjei, Alex.

In: Translational Lung Cancer Research, Vol. 6, 01.12.2017, p. S41-S43.

Research output: Contribution to journalEditorial

@article{fd49b59ee2014722925bec5ee8ecc805,
title = "Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer",
author = "Hao Xie and Alex Adjei",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/tlcr.2017.10.15",
language = "English (US)",
volume = "6",
pages = "S41--S43",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",

}

TY - JOUR

T1 - Avelumab

T2 - Another active immune checkpoint inhibitor in nonsmall cell lung cancer

AU - Xie, Hao

AU - Adjei, Alex

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85038608456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038608456&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2017.10.15

DO - 10.21037/tlcr.2017.10.15

M3 - Editorial

AN - SCOPUS:85038608456

VL - 6

SP - S41-S43

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

ER -